Prof. Fabrice Barlesi is General Director of Gustave Roussy and Professor specialising in thoracic oncology at Paris-Saclay University. He formerly headed the Multidisciplinary Oncology and Innovative Therapies Department at Nord Hospital in Marseille and established the Marseille Centre for Early Trials in Oncology (CLIP2). A co-founder of the Marseille Immunopôle network and leader of the international PIONeeR project on resistance to anti-PD1/L1 immunotherapy in lung cancer, he has authored approximately 400 articles in international journals. He received the prestigious ESMO/IASLC Heine H. Hansen Prize in 2018 and is listed among the world’s most influential researchers (Highly Cited Researchers, Web of Science, 2024).